When the hospital grows bigger than the person who built it
At 9:15 on a Monday morning, the CEO of a 400-bed hospital was sitting outside the promoter’s office. He had come with a fairly straightforward proposal. A new oncology programme needed ₹8 crore of investment. The clinical team had prepared the business case. Finance had worked out the projected returns. The doctors had estimated the patient volumes. Operations had identified the space.
The CEO had one question left. “Sir, can we take this to the Board?”
The promoter looked at the file.
“Why do we need the Board?”
The CEO paused. That question, in many promoter-led hospitals, is not unusual. In fact, it is often the way the organisation has operated for years. The promoter started the hospital. He hired the first doctors. He negotiated the first bank loan. He knew which consultant could be trusted, which supplier would deliver on time and which local doctor could influence referrals.
When the hospital had 50 beds, this model worked beautifully. The promoter could walk through the hospital, speak to the medical superintendent, call the CFO, meet a consultant and make five decisions before lunch.
The problem begins when the hospital becomes 400 beds.
Then 800 beds.
Then three hospitals.
Then five cities.
The same promoter who was once the organisation’s greatest strength can slowly become its biggest decision bottleneck. Not because the promoter has changed. Because the organisation has.
A moment a hospital outgrows its promoter
This is one of the least discussed transitions in Indian healthcare. Hospitals are often born from a promoter’s conviction. A doctor decides that his city needs better tertiary care. A family puts its savings into a hospital. An entrepreneur sees an underserved geography. A promoter mortgages asset, raises debt, brings in partners and builds the first facility.
In the early years, the promoter’s judgement is the institution’s operating system. But scale changes the equation. A 50-bed hospital may have one major decision-maker.
A 500-bed network may have:
- multiple clinical specialties,
- hundreds of doctors,
- thousands of employees,
- multiple locations,
- institutional lenders,
- investors,
- regulators,
- insurance companies,
- technology partners,
- complex capital allocation decisions,
- and, most importantly, thousands of patients whose interests cannot depend on one person’s availability.
At some point, the question is no longer:
“Is the promoter making good decisions?”
The question becomes:
“Can the institution make good decisions even when the promoter isn’t in the room?”
That is the real beginning of institutionalisation. And this is where the story of hospital governance becomes interesting.
1. Promoter-Led vs Institution-Led: It Is Not About Removing the Promoter
There is a temptation to describe institutionalisation as a battle between the promoter and the Board.
It isn’t.
Look at the evolution of large Indian healthcare organisations.
Apollo Hospitals, for example, remains deeply associated with its founding family. Yet over time its governance architecture has evolved to include independent directors, formal Board committees and defined governance structures. Apollo’s published governance material shows the Founder and Executive Chairman alongside non-executive and independent directors, with committees covering areas such as audit, nomination and remuneration, risk, investment, innovation and quality.
That distinction matters. “ Institutionalisation does not mean the promoter becomes irrelevant.”
It means the promoter’s job changes. When the hospital is young, the promoter may ask:
“Why are we spending ₹20 lakh on this?”
As the organisation matures, the better question is:
“What decision-making framework should determine whether we spend ₹20 crore on this?”
The first is control. The second is governance. The first depends on the promoter’s judgement. The second creates institutional judgement. And that is the transition that many growing hospitals struggle to make.
2. Why Hospital Governance Is Different
A hospital Board cannot look at the business in the same way a manufacturing company’s Board might. Imagine a hospital Board meeting.The CFO presents the numbers.
- Revenue is up 14%.
- EBITDA is up 11%.
- Occupancy has improved.
The Board is satisfied.
Then the Medical Director quietly adds one slide.
- ICU infection rates have increased.
- A sentinel event occurred last month.
- Doctor attrition in one critical specialty has doubled.
Suddenly, the picture changes.
The hospital is financially healthier. But is the institution healthier? This is what makes healthcare governance unusual. A hospital is simultaneously managing:
“ patient safety, clinical quality, doctors, employees, capital, regulation, reputation and financial performance.”
The Board therefore cannot govern only through the P&L. It needs to understand the organisation through multiple lenses.
- Financial performance tells you what happened.
- Clinical governance often tells you what happened to the patient.
- Patient experience tells you how the organisation was perceived.
- People metrics tell you whether the organisation can sustain the performance.
- Growth metrics tell you whether today’s performance can become tomorrow’s institution.
A hospital Board that sees only EBITDA may be financially informed. It may not be institutionally informed.
3. The Three People Sitting Around the Same Table
Imagine a ₹1,000-crore hospital group considering to start a new 300-bed facility. The promoter wants the expansion. The CEO believes the market can support it. The CFO is worried about the capital employed. The Medical Director wants the clinical programme to be built properly.
The Board asks a simple question “Who owns this decision?” This is where governance architecture matters. Think of hospital governance as three different floors of the same building.
Floor 1: Ownership
The promoter and shareholders decide:
- Where are we going?
- What is our long-term ambition?
- Where should capital be deployed?
- What level of risk are we willing to take?
- What return do we expect?
Floor 2: Governance
The Board asks:
- Are we going there responsibly?
- Is the strategy sound?
- Are risks controlled?
- Is management performing?
- Are patients and stakeholders protected?
- Has management challenged its own assumptions?
Floor 3: Execution
The CEO and management ask:
- How do we get there?
- Who will execute?
- What resources are needed?
- What needs to change?
- What corrective action is required?
The problem starts when the floors collapse into one another. The promoter starts running operations. The Board starts discussing daily staffing. The CEO waits for permission to make routine decisions. And suddenly everyone is busy. But nobody is quite sure who is accountable. That is not governance. That is organisational traffic.
4. What Should Actually Come to the Board?
One of the easiest ways to understand governance is to imagine the Board agenda without the word “Board.” Suppose the first item is: “Consultant needs approval for a ₹3 lakh conference sponsorship.” Should the Board spend 30 minutes discussing it? Probably not.
Now change the question:
“Should the hospital invest ₹50 crore in building a new robotic surgery programme?”
Now the Board needs to understand the strategic rationale, clinical capability, capital requirement, expected utilisation, competitive environment, risk and return. The difference is not the amount alone. It is the nature of the decision.
A useful governance framework divides decision into three buckets.
Board decisions
- Strategy.
- Major capital expenditure.
- Acquisitions.
- New hospitals.
- Debt.
- Senior leadership appointments.
- Major related-party transactions.
- Risk appetite.
Management decisions
- Hiring within approved structures.
- Vendor decisions.
- Marketing campaigns.
- Doctor engagement.
- Daily operational decisions.
- Routine financial management.
Board oversight
- Clinical quality.
- Patient safety.
- Financial performance.
- Compliance.
- Risk.
- People.
- Reputation.
The Board should not become the management team. And management should not become the Board. A good Board creates challenge without interference. A good management team accepts accountability without dependency. That is easier to write than to practise. Which is why the next question becomes even more important: Who sits around the Board table?
5. The Boardroom Test: Who Can Challenge the Promoter?
There is a simple test for any promoter-led hospital. Imagine the promoter walks into the Board meeting and says:
“I think we should acquire this hospital.”
Then ask:
Who in the room is expected to say, “I don’t think we should”?
If the answer is nobody, you don’t really have a Board. You have an audience. The purpose of independent and non-executive directors is not to oppose the promoter. It is to ensure that important decisions receive independent scrutiny.
Large healthcare organisations have increasingly formalised this architecture. Apollo, for example, publicly discloses independent directors and formal Board committees, while Max Healthcare’s current governance structure includes independent directors and committees for audit, risk management, nomination and remuneration, IT strategy and other areas.
The lesson for a growing hospital is not:
“Copy Apollo.”
The lesson is:
“Build enough institutional capability around the promoter that the organisation can challenge its own assumptions.”
The best Board is not the one where everyone agrees quickly. It is the one where the right questions are asked before the money is spent, the risk is taken or the patient is affected.
6. Designing the Right Hospital Board
A promoter once told me something that sounded perfectly logical.
“I don’t need an independent director to tell me how to run my hospital. I built it.”
There is truth in that statement. The promoter probably does know the hospital better than anyone else. He knows the history. He remembers the first bank loan. He remembers which doctor joined when there was barely enough money to pay salaries. He remembers the difficult years. He remembers the day the first 100 patients crossed the hospital’s doors. But there is one thing even the most experienced promoter cannot know.
What he cannot see from inside the organisation. That is the reason a Board needs people who are not emotionally invested in every decision. Not people who will automatically oppose the promoter. Not people who will automatically agree with him.
People who can ask:
“What if your assumption is wrong?”
That is the real value of an independent Board. Look at the evolution of large listed healthcare organisations.
Apollo’s published governance disclosures show a Board with independent directors and multiple committees covering areas such as audit, risk, investment, nomination and remuneration, and innovation and quality. Apollo explicitly describes its governance structure as a combination of Board oversight and management execution.
Max Healthcare’s current governance structure similarly includes independent directors and formal committees for audit, risk management, nomination and remuneration, IT strategy and other areas.
The lesson isn’t that every hospital needs the same Board. It is that scale demands different kinds of thinking around the table.
A growing hospital may need:
- Promoter/shareholder representation
- Healthcare and clinical expertise
- Finance and capital allocation expertise
- Strategy and business expertise
- Risk and governance expertise
- Technology expertise
- Independent voices
- CEO representation
But there is another question that is more important than the composition.
Can someone sitting at that table disagree with the promoter without worrying about the consequences?
If the answer is no, the Board may have the right people on paper and the wrong governance culture in practice.
The practical framework
Before appointing a director, ask five questions:
- What expertise does the Board already have?
- What expertise is missing?
- Who can challenge strategic assumptions?
- Who understands clinical risk?
- Who understands capital and financial risk?
A Board should be designed around capability gaps, not relationships.
Ask yourself
If the promoter proposes a ₹100-crore expansion tomorrow, who around the table has both the authority and the independence to say, “Let’s examine that assumption again”?
7. The Board Committee Architecture
A Board can be made up of excellent people and still become ineffective. The reason is simple. Everything gets discussed in one room.
- Audit.
- Clinical quality.
- Doctor compensation.
- Capex.
- Cybersecurity.
- Expansion.
- Employee attrition.
- Patient complaints.
By the time the Board reaches the important strategic question, everyone is tired. This is why mature organisations don’t expect the full Board to examine every issue with the same depth.
They create smaller committees.
Apollo’s current governance disclosures, for example, identify multiple Board committees with defined responsibilities, including Audit, Risk Management, Investment, Nomination & Remuneration and Innovation & Quality. Apollo says these committees operate within defined frameworks.
Max Healthcare similarly has formal committees including Audit, Risk Management, Nomination & Remuneration, IT Strategy, ESG and others.
Why does this matter?
Imagine a clinical quality committee discussing a rise in ICU infections. The discussion should not be:
“Why has this happened?” followed by “Who is responsible?” and then “Let’s move on.” It should go deeper.
- Is this a one-off?
- Is there a pattern?
- Is it unit-specific?
- Is it linked to staffing?
- Are protocols being followed?
- Are there reporting gaps?
- What corrective action has been taken?
- Who is monitoring it?
That is governance. Not because the Board is treating patients. But because the Board is making sure the institution has a system that protects patients.
The practical framework
A hospital’s committee architecture can broadly include:
- Audit & Finance: Financial reporting, controls, cash, audit, related-party transactions.
- Clinical Quality & Patient Safety: Clinical outcomes, mortality, infections, sentinel events, patient safety.
- Nomination & Remuneration: Leadership succession, CEO evaluation, senior management and compensation.
- Risk & Compliance: Regulatory, legal, cybersecurity, enterprise risk.
The exact number of committees should depend on the size and complexity of the organisation. The objective is not to create more meetings. It is to create better accountability.
Ask yourself: “Are your committees helping the Board understand difficult issues—or are they simply creating another layer of meetings and minutes?
8. The Board Dashboard: What Should Directors See Every Month?
There was a time when a 100-page MIS pack was considered a sign of a well-managed hospital.
- More pages.
- More tables.
- More numbers.
- More intelligence.
But somewhere along the way, healthcare organisations confused more information with better governance.
Imagine a Board member opening a monthly pack.
- Page 1: Revenue.
- Page 2: Revenue by specialty.
- Page 3: Revenue by consultant.
- Page 4: Revenue by payer.
- Page 5: Revenue by location.
- Page 6: Revenue versus budget.
By page 70, the Board has learned almost everything about revenue. But perhaps nothing about the patient who died unexpectedly in the ICU last week. The Board doesn’t need every piece of information. It needs the right signals.
Apollo’s governance philosophy explicitly places responsibility on the Board for oversight while giving management the freedom to execute within an agreed framework.
That philosophy should also determine the Board dashboard.
A one-page institutional dashboard
- Financial: Revenue | EBITDA | Cash | AR | Capex
- Clinical: Mortality | Infection | Readmission | Sentinel events
- Customer: NPS | Complaints | Patient experience
- Growth: OPD | IP | Occupancy | New specialties | New markets
- People: Attrition | Critical vacancies | Doctor retention | Employee engagement
- Risk: Open critical risks | Compliance gaps | Major incidents
The Board should not spend its time asking: “Why did OPD fall by 3%?”
It should be asking:
“Why has OPD fallen for three consecutive months, and what is management doing about it?”
That is the difference between monitoring numbers and governing outcomes.
The practical framework
Every Board dashboard should answer five questions:
- What happened?
- Why did it happen?
- What is the risk?
- What action has management taken?
- What decision does the Board need to make?
If the dashboard cannot answer these questions, it is probably a reporting document, not a governance document.
Ask yourself
If you removed 80% of the pages from your current Board pack, which 20% would actually change a Board decision?
9. The Most Important Element: Decision Rights
This is where many promoter-led organisations struggle. Consider a hospital that wants to open a new 100-bed unit. The promoter has an idea. The CEO prepares a proposal. The CFO builds the financial model. The Medical Director evaluates the clinical requirement. Operations assesses execution. The Board considers the investment.
Who decides?
This sounds obvious.
Until you ask the next question:
Who is accountable if the decision goes wrong?
That is where governance becomes practical. A mature institution makes decision rights explicit. For every significant decision, five questions should be answered:
- Who recommends?
- Who decides?
- Who executes?
- Who monitors?
- Who is accountable?
Take a ₹10-crore expansion.
- The promoter may establish the strategic intent.
- The CEO may build the business case.
- The CFO may test the economics.
- The clinical leadership may validate clinical feasibility.
- The Board may approve the investment.
- Management then executes.
The promoter doesn’t need to approve every procurement order during construction. The Board doesn’t need to decide the colour of the hospital signage. That sounds obvious. Yet many organisations fail precisely because these boundaries are not clear. The result is predictable. Managers stop taking decisions. They start asking for approvals.
- Approvals increase.
- Decision speed falls.
- The promoter becomes overloaded.
- And eventually everyone complains:
- “Nothing moves without the promoter.”
- But the promoter is not necessarily the problem.
The system is.
The practical framework
Create a Delegation of Authority matrix covering:
- Capital expenditure
- Hiring
- Procurement
- Vendor selection
- Pricing
- Discounts
- Doctor contracts
- New specialties
- New locations
- Marketing expenditure
- Borrowing
- Related-party transactions
For each, define the approval authority and escalation threshold.
Institutional governance begins when people know “ what they are empowered to decide without asking.”
Ask yourself
How many decisions in your hospital are genuinely difficult—and how many are simply waiting for someone senior enough to approve them?
10. From Founder Knowledge to Institutional Knowledge
A promoter walks into the hospital and says:
“Don’t use that vendor.”
The procurement team asks:
“Why?”
The promoter replies:
“I know them.”
End of discussion.
Now imagine that promoter is travelling for three months. What happens? The organisation discovers that the reason behind the decision exists only in the promoter’s memory. This is a common feature of entrepreneurial organisations. The founder carries enormous amounts of invisible institutional knowledge.
- Who can be trusted.
- Which market is difficult.
- Which doctor is likely to leave.
- Which supplier has a history of delays.
- Which investment almost went wrong ten years ago.
The problem isn’t that this knowledge exists in the promoter’s head. The problem is when, it never leaves the promoter’s head. That is where institutional memory becomes important.
- SOPs are not bureaucracy.
- Delegation matrices are not bureaucracy.
- Board minutes are not bureaucracy.
- Risk registers are not bureaucracy.
- Succession plans are not bureaucracy.
They are the organisation’s memory.
A mature institution should be able to answer:
- Why did we make this decision?
- What assumptions did we use?
- What did we learn?
- What would we do differently today?
That is how experience becomes organisational capability.
The practical framework
Institutionalise five things:
- Decisions — documented rationale for major decisions.
- Processes — SOPs and defined workflows.
- Authority — Delegation of Authority.
- Risk — risk register and escalation mechanism.
- Leadership — succession plans for critical roles.
The objective isn’t to eliminate judgement. It is to ensure that judgement becomes repeatable organisational capability.
Ask yourself
If your promoter, CEO and CFO were all unavailable for 90 days, how much of the organisation’s critical knowledge would disappear with them?
11. The Promoter’s New Role
Perhaps this is the most sensitive part of the transition. Because institutionalisation can sound like a polite way of saying:
“The promoter needs to step aside.”
That is not the point. The promoter should not become less important. The promoter should become different. Think about a founder who once personally approved every major decision.
At 50 beds, that may have been leadership. At 500 beds, it can become a bottleneck.The promoter’s role therefore evolves.
From:
“I approve everything.”
To:
“I make sure the institution makes good decisions.”
From:
Operational control
To:
Strategic stewardship
From:
Managing today’s hospital
To:
Building tomorrow’s institution
That is a difficult transition. Because delegation can feel like loss of control. But institutionalisation is not about giving away control. It is about creating an organisation capable of carrying the promoter’s vision beyond the promoter’s personal involvement.
Apollo’s governance disclosures offer an interesting real-world illustration of this coexistence: the organisation continues to identify Dr. Prathap C. Reddy as Founder and Executive Chairman, while its governance architecture includes independent directors, Board committees and a defined management structure.
That is an important distinction.
Founder influence and institutional governance are not mutually exclusive.
The real test is whether one can exist without paralysing the other.
The practical framework
The promoter should increasingly focus on:
- Vision: Where should the organisation go?
- Capital: Where should capital be deployed?
- Leadership: Who should lead the organisation?
- Governance: What standards should the institution operate by?
- Reputation: What should the organisation stand for?
The promoter should gradually spend less time deciding what colour the walls should be and more time deciding what the institution should become.
Ask yourself
If the promoter’s calendar is still filled with operational approvals, is the organisation really scaling—or is the promoter simply carrying a larger hospital on his shoulders?
12. The 90-Day Hospital Governance Playbook
Institutionalisation sounds impressive until someone asks:
“Where do we start?”
The answer doesn’t require a three-year transformation programme. Start with 90 days.
Days 1–30: Diagnose
Don’t redesign anything yet. First understand how decisions are actually made.
Map:
- What decisions require promoter approval?
- What decisions require Board approval?
- Where does the CEO have authority?
- Where are decisions getting delayed?
- Which committees exist?
- Which committees actually work?
- What does the Board currently see?
- Where are the biggest governance risks?
Then ask employees a deceptively simple question:
“What decisions can you make without asking anyone?”
The answers will tell you more about the real organisation than the organisation chart.
Days 31–60: Design
Now build the architecture.
Define:
- Board calendar: What should the Board discuss monthly, quarterly and annually?
- Decision rights: Who recommends, approves and executes?
- Board dashboard: What are the 15–20 signals that matter?
- Committees: Which committees are genuinely required?
- Escalation framework: Which risks need immediate escalation?
The objective is not to create more governance. It is to create clarity.
Days 61–90: Institutionalise
Now make the system operate. Run the Board meeting using the new dashboard.
- Run the committees.
- Track actions.
- Measure closure.
- Document decisions.
- Review delegation.
- Identify leadership gaps.
- Begin succession planning.
And after 90 days, ask the most important question:
Has decision-making become better—or have we simply created more paperwork?
Because governance is successful only when it improves the quality of decisions.
13. The Institutionalisation Test
At the end of the exercise, there is no need for a complicated governance scorecard.
Ask ten uncomfortable questions.
- Can the CEO make most operational decisions without waiting for promoter approval?
- Can the Board challenge management constructively?
- Does the Board review clinical outcomes with the same seriousness as financial performance?
- Are decision rights clearly documented?
- Is there a succession plan for the CEO and other critical leaders?
- Can the hospital operate effectively if the promoter is absent for 90 days?
- Are major capital decisions evaluated against defined investment criteria?
- Does the Board receive signals rather than hundreds of pages of data?
- Are risks discussed before they become crises?
- Is the organisation building capabilities that survive individual personalities?
If the answer to most of these is “yes”, the organisation is moving towards institutionalisation. If the answer is “no”, don’t blame the promoter. The organisation probably hasn’t yet built the system that allows the promoter to step back.
The Final Question
Every promoter eventually faces a version of the same choice.
Build a bigger hospital or build an institution capable of building bigger hospitals. They sound like the same ambition. But they aren’t. The first is about scale & the second is about sustainability.
A promoter can personally drive a 50-bed hospital. A strong promoter can probably drive a 200-bed hospital. But when the organisation reaches multiple hospitals, multiple cities, institutional capital and thousands of employees, the question changes. The organisation can no longer depend on one person’s memory, relationships and judgement.
It needs something bigger. It needs systems. It needs capable leaders. It needs independent challenge. It needs clear decision rights. It needs institutional memory. And above all, it needs governance that allows the organisation to make good decisions even when the founder isn’t in the room.
A hospital becomes an institution not when the promoter becomes less important, but when the organisation becomes capable of succeeding beyond the promoter.
That is perhaps the real measure of a promoter’s legacy. Not: “How many hospitals did I build?” But: “Did I build an institution that can continue building them after me?”